QQQ   431.56 (+0.12%)
AAPL   168.55 (-2.40%)
MSFT   416.27 (+0.64%)
META   501.67 (+0.29%)
GOOGL   154.55 (-0.20%)
AMZN   183.99 (+0.20%)
TSLA   157.92 (-2.20%)
NVDA   871.24 (+1.31%)
AMD   163.60 (+2.05%)
NIO   3.81 (-2.06%)
BABA   69.33 (-1.83%)
T   16.02 (-1.35%)
F   12.09 (-1.14%)
MU   121.01 (-0.30%)
GE   154.59 (+0.58%)
CGC   7.00 (+0.29%)
DIS   114.00 (+0.93%)
AMC   2.69 (+8.91%)
PFE   25.89 (-0.08%)
PYPL   63.81 (+0.47%)
XOM   118.88 (-0.67%)
QQQ   431.56 (+0.12%)
AAPL   168.55 (-2.40%)
MSFT   416.27 (+0.64%)
META   501.67 (+0.29%)
GOOGL   154.55 (-0.20%)
AMZN   183.99 (+0.20%)
TSLA   157.92 (-2.20%)
NVDA   871.24 (+1.31%)
AMD   163.60 (+2.05%)
NIO   3.81 (-2.06%)
BABA   69.33 (-1.83%)
T   16.02 (-1.35%)
F   12.09 (-1.14%)
MU   121.01 (-0.30%)
GE   154.59 (+0.58%)
CGC   7.00 (+0.29%)
DIS   114.00 (+0.93%)
AMC   2.69 (+8.91%)
PFE   25.89 (-0.08%)
PYPL   63.81 (+0.47%)
XOM   118.88 (-0.67%)
QQQ   431.56 (+0.12%)
AAPL   168.55 (-2.40%)
MSFT   416.27 (+0.64%)
META   501.67 (+0.29%)
GOOGL   154.55 (-0.20%)
AMZN   183.99 (+0.20%)
TSLA   157.92 (-2.20%)
NVDA   871.24 (+1.31%)
AMD   163.60 (+2.05%)
NIO   3.81 (-2.06%)
BABA   69.33 (-1.83%)
T   16.02 (-1.35%)
F   12.09 (-1.14%)
MU   121.01 (-0.30%)
GE   154.59 (+0.58%)
CGC   7.00 (+0.29%)
DIS   114.00 (+0.93%)
AMC   2.69 (+8.91%)
PFE   25.89 (-0.08%)
PYPL   63.81 (+0.47%)
XOM   118.88 (-0.67%)
QQQ   431.56 (+0.12%)
AAPL   168.55 (-2.40%)
MSFT   416.27 (+0.64%)
META   501.67 (+0.29%)
GOOGL   154.55 (-0.20%)
AMZN   183.99 (+0.20%)
TSLA   157.92 (-2.20%)
NVDA   871.24 (+1.31%)
AMD   163.60 (+2.05%)
NIO   3.81 (-2.06%)
BABA   69.33 (-1.83%)
T   16.02 (-1.35%)
F   12.09 (-1.14%)
MU   121.01 (-0.30%)
GE   154.59 (+0.58%)
CGC   7.00 (+0.29%)
DIS   114.00 (+0.93%)
AMC   2.69 (+8.91%)
PFE   25.89 (-0.08%)
PYPL   63.81 (+0.47%)
XOM   118.88 (-0.67%)
Free Trial
NYSEARCA:PBE

Invesco Biotechnology & Genome ETF (PBE) Price, Holdings, & News

→ A.I. “Perfect Storm” Could Send THESE Stocks Sky High (From InvestorPlace) (Ad)
Free PBE Stock Alerts
$60.71
-0.62 (-1.01%)
(As of 04/15/2024 ET)
Compare
Today's Range
$60.65
▼
$61.46
50-Day Range
$60.71
▼
$67.29
52-Week Range
$52.47
▼
$67.76
Volume
12,374 shs
Average Volume
12,408 shs
Market Capitalization
$230.70 million
Assets Under Management
$230.19 million
Dividend Yield
0.06%
Net Expense Ratio
0.58%
Stock AnalysisChartHeadlinesHoldingsOwnershipRatings
PBE stock logo

About Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies. The Fund will normally invest at least 90% of its total assets in common stocks that consists of the Index. The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. Invesco PowerShares Capital Management LLC acts as the Fund’s investment adviser.

PBE Stock Price History

PBE ETF News Headlines

March 22, 2024 | msn.com
Invesco Dynamic Biotechnology & Genome ETF declares quarterly distribution of $0.0242
February 19, 2024 | investorplace.com
3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential
April 16, 2024 | InvestorPlace (Ad)
A.I. “Perfect Storm” Could Send THESE Stocks Sky High
A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.
February 14, 2024 | msn.com
Where Are Biotech ETFs Headed After Q4 Earnings?
December 22, 2023 | uk.investing.com
Invesco MSCI USA ESG Universal Screened UCITS ETF USD Distribution
December 14, 2023 | uk.investing.com
Invesco Markets plc - Invesco S&P China A 300 Swap UCITS ETF
November 27, 2023 | lse.co.uk
Invesco Nasdaq Biotech Ucits Etf Share Price (SBIO.AM)
November 25, 2023 | wsj.com
Invesco Biotechnology & Genome ETF
April 16, 2024 | InvestorPlace (Ad)
A.I. “Perfect Storm” Could Send THESE Stocks Sky High
A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.
November 16, 2023 | lse.co.uk
Invesco Msci World Esg Screen Ucits Etf Share Price (ESGW.MI)
See More Headlines
Receive PBE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Invesco
Fund Name
Invesco Biotechnology & Genome ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:PBE
Inception Date
6/23/2005
Fund Manager
Peter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser
Web
www.invescopowershares.com
Phone
+1-800-9830903

Fund Focus

Asset Class
Equity
Benchmark
Dynamic Biotech & Genome Intellidex Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
34

Fund Statistics

Assets Under Management
$232.51 million
Average Daily Volume
$5,809.30
Discount/Premium
-0.02%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Invesco Capital Management LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Invesco Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
N/A
Short Interest
9,000 shs

Miscellaneous

Outstanding Shares
3,800,000
Beta
0.92
Creation Unit
10,000
Creation Fee
$500.00
12 Stocks Corporate Insiders are Abandoning Cover
12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Ad InvestorPlace
A.I. “Perfect Storm” Could Send THESE Stocks Sky High
A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.
>>Check out what this A.I. Perfect Storm is<<

Invesco Biotechnology & Genome ETF Expenses

TypePBEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.50%0.56%0.54%0.50%0.51%
Other Expenses0.08%0.40%0.54%0.64%0.58%
Total Expense0.58%0.72%0.70%0.74%0.70%
Fee Waiver0.00%-0.53%-0.55%-0.68%-0.57%
Net Expense0.58%0.60%0.60%0.57%0.58%

Invesco Biotechnology & Genome ETF (PBE) Holdings & Exposure

Top 10 PBE Holdings

PBE Sector Exposure

PBE Industry Exposure

Full Holdings Details

PBE ETF - Frequently Asked Questions

How have PBE shares performed in 2024?

Invesco Biotechnology & Genome ETF's stock was trading at $65.84 at the start of the year. Since then, PBE stock has decreased by 7.8% and is now trading at $60.71.
View the best growth stocks for 2024 here.

What does PBE invest in?

Invesco Biotechnology & Genome ETF is a equity fund issued by Invesco. PBE focuses on health care investments and follows the Dynamic Biotech & Genome Intellidex Index. The fund's investments total to approximately $230.19 million assets under management.

What stocks does Invesco Biotechnology & Genome ETF hold?

PBE invests in 31 holdings. Some of the stocks in their portfolio include Neurocrine Biosciences (NBIX), Bio-Techne (TECH), BioMarin Pharmaceutical (BMRN), Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Amgen (AMGN), Biogen (BIIB), MannKind (MNKD) and Collegium Pharmaceutical (COLL).

What is the management fee for Invesco Biotechnology & Genome ETF?

Invesco Biotechnology & Genome ETF's management fee is 0.50% and has other expenses of 0.08%. The net expense ratio for PBE is 0.58%.

What other stocks do shareholders of Invesco Biotechnology & Genome ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco Biotechnology & Genome ETF investors own include Pfizer (PFE), Intel (INTC), Align Technology (ALGN), Micron Technology (MU), Activision Blizzard (ATVI), DocuSign (DOCU), Inovio Pharmaceuticals (INO), Mastercard (MA), Hello Group (MOMO) and ONEOK (OKE).

Who are Invesco Biotechnology & Genome ETF's major shareholders?

Invesco Biotechnology & Genome ETF's stock is owned by many different institutional and retail investors. Top institutional investors include Banque Cantonale Vaudoise (0.13%).

How do I buy shares of Invesco Biotechnology & Genome ETF?

Shares of PBE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:PBE) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
He Is Giving Away Bitcoin
Crypto Swap Profits
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Options trading has suddenly become more reliable.
Eagle Publishing
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
The #1 Crypto for 2024
InvestorPlace
The Greatest Bull Market in Crypto History…
Weiss Ratings